Pharmacists in Oak Hill, West Virginia


13 Pharmacists found in Oak Hill
female pharmacist

Amanda Miller


Pharmacist
411 Mall Rd, Oak Hill, WV 25901
304-465-0321    

male pharmacist

Hafiz Syed K Ali


Pharmacist
435 Main St W, Oak Hill, WV 25901
304-465-7200     304-465-0377

female pharmacist

Jennifer Zamias


Pharmacist
411 Mall Rd, Oak Hill, WV 25901
304-465-0321    



male pharmacist

Mr. John Douglas Mcclain, RPH


Pharmacist
435 Main St W, Oak Hill, WV 25901
304-465-7200     304-465-0377

female pharmacist

Miss Kathryn Ann Hume, RPH


Pharmacist
411 Mall Rd, Oak Hill, WV 25901
304-465-0321     304-469-8892

female pharmacist

Kathy L. Sumner, RPH


Pharmacist
9000 Fayetteville Road, Oak Hill, WV 25901
304-469-6091     304-469-2914

female pharmacist

Leslie Dawn Groves, PHARM D.


Pharmacist
1201 Main St E, Oak Hill, WV 25901
304-465-5658    

male pharmacist

Mr. Robert Rosiek, R.PH.


Pharmacist
411 Mall Rd, Oak Hill, WV 25901
304-465-0321     304-469-8892

male pharmacist

Dr. Ronald F. Lilly, BSPHARM,RPH, PD


Pharmacist
430 Main St W, Plateau Medical Center Pharmacy, Oak Hill, WV 25901
304-465-5785     304-929-2465

female pharmacist

Stephanie Arrington


Pharmacist
400 Virginia St, Oak Hill, WV 25901
304-469-2923     304-469-2984

female pharmacist

Susan Woods


Pharmacist
1201 Main St E, Oak Hill, WV 25901
304-465-5658     304-465-3662

female pharmacist

Teresa Rosiek, RPH


Pharmacist
411 Mall Rd, Oak Hill, WV 25901
304-465-0321     304-469-8892

male pharmacist

Mr. Tommy Hamilton Stanley, RPH


Pharmacist
9000 Fayetteville Rd, Oak Hill, WV 25901
304-469-6091     304-469-2914


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.